Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Quarterly results
|
|
PTC THERAPEUTICS, INC. (PTCT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/28/2023 |
8-K
| Quarterly results |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 07/19/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 07/17/2023 |
4
| Gravier Pierre (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 26,000 shares
@ $0
Granted 65,000 options to buy
@ $39.82, valued at
$2.6M
|
|
| 07/17/2023 |
3
| Gravier Pierre (CFO) has filed a Form 3 on PTC THERAPEUTICS, INC. |
| 07/17/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/09/2023 |
4
| SCHMERTZLER MICHAEL (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 1,000 shares
@ $44.86, valued at
$44.9k
|
|
| 06/07/2023 |
4
| Bell William F. Jr. (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 4,000 shares
@ $0
Granted 2,333 shares
@ $0
Granted 10,000 options to buy
@ $45.015, valued at
$450.2k
Granted 5,834 options to buy
@ $45.015, valued at
$262.6k
|
|
| 06/07/2023 |
3
| Bell William F. Jr. (Director) has filed a Form 3 on PTC THERAPEUTICS, INC. |
| 06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/06/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits Interactive Data |
| 05/24/2023 |
4
| Reeve Emma (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 173 shares
@ $59.5242, valued at
$10.3k
Sold 2,995 shares
@ $59.5335, valued at
$178.3k
Sold 3,948 shares
@ $59.5313, valued at
$235k
Sold 157 shares
@ $59.5171, valued at
$9.3k
Sold 1,093 shares
@ $59.532, valued at
$65.1k
Sold 1,402 shares
@ $59.5378, valued at
$83.5k
Exercised 173 options to buy
@ $33.63, valued at
$5.8k
Exercised 2,995 options to buy
@ $33.02, valued at
$98.9k
Exercised 3,948 options to buy
@ $33.63, valued at
$132.8k
Exercised 157 options to buy
@ $33.63, valued at
$5.3k
Exercised 1,093 options to buy
@ $33.02, valued at
$36.1k
|
|
| 05/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/23/2023 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
| 05/23/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 6,403 shares
@ $58.9553, valued at
$377.5k
Sold 1,913 shares
@ $58.9783, valued at
$112.8k
Sold 100 shares
@ $59.66, valued at
$6k
|
|
| 05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 800 shares
@ $58.5175, valued at
$46.8k
Sold 7,248 shares
@ $58.5, valued at
$424k
Sold 788 shares
@ $58.7143, valued at
$46.3k
|
|
| 05/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/08/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 05/05/2023 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 04/28/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 04/27/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/27/2023 |
8-K
| Quarterly results |
| 04/26/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/26/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/26/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
|
|
|